Aether uses its state of the art platform to rapidly engineer enzymes, enabling our customers to manufacture complex and novel products at fractional cost.
Aether is the first company capable of searching sequence space to find novel biocatalysts. Our technology can design enzymes for an ever increasing range of chemistries, all in timelines that fit your schedule.
Commercially available automation falls short of the throughputs required to index sequence space.
Even recent improvements to automation fall short of the throughputs required to index sequence space.
Aether’s proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.
As Google mapped the internet, Aether maps trillions of enzymes to create a searchable index.
We’re selectively taking on new clients today.
We are a passionate group of hardware nerds, coders, machine learning engineers, and biologists working to build a better future for humankind. Join us.
We’re backed by an incredible roster of investors who understand our boundary-pushing work and see its potential to trigger a new industrial revolution.
